The differences in inflammation scores, as well as LCA and p62 levels, between the baseline and control groups, illustrate the dynamic nature of autophagic activity and immune responses during NAFLD progression. This evidence concerns the gene SQSTM1 and metabolic dysfunction-associated steatotic liver disease.